Search - tctmd.com

Displaying 201 - 220 of 4990

Sort: Relevancy | Date

Presentation TCT 2016

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Michael Haude

November 01, 2016

Presentation TCT 2016

The Case for Multivessel PCI

Presenter: John A. Bittl, David J. Maron, Sripal Bangalore

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

Presenter: Fernando Alfonso, Juan F. Granada, Bernardo Cortese

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly

November 01, 2016

Presentation TCT 2016

The Case for CABG

Presenter: John A. Bittl, David J. Maron, A. Pieter Kappetein

November 01, 2016

Presentation TCT 2016

To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT

Presenter: Gregg W. Stone, Ron Waksman, Seung-Jung Park

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? No, Much Ado About Nothing!

Presenter: Adrian P. Banning, Nick Curzen, Samir B. Pancholy

November 01, 2016

Presentation TCT 2016

The Case for a Trial of Medical Therapy

Presenter: John A. Bittl, David J. Maron, Michael E. Farkouh

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Presenter: Adrian P. Banning, Nick Curzen, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation

Presenter: Howard C. Herrmann, Robert J. de Winter, Hiroki Shiomi

November 01, 2016

Presentation TCT 2016

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

Presenter: Gregg W. Stone, Ron Waksman, Vasim Farooq

November 01, 2016

Presentation TCT 2016

2016 CTO Revascularization Update

Presenter: Sripal Bangalore, George D. Dangas, Khaldoon Alaswad

November 01, 2016

Presentation TCT 2016

PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities

Presenter: Howard C. Herrmann, Robert J. de Winter, Wayne B. Batchelor

November 01, 2016

Presentation TCT 2016

Diagnosis and Treatment of Erosion in ACS: The EROSION Study

Presenter: John A. Ambrose, Peter H. Stone, Ik-Kyung Jang

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Revascularize This Patient?

Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016!

Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Hitinder S. Gurm

November 01, 2016

Presentation TCT 2016

Designing a Complication-Free DCB: Is It Possible or Necessary?

Presenter: Koen Deloose, William A. Gray, Juan F. Granada

November 01, 2016

Advertisement

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

The Case for Multivessel PCI

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

The Case for CABG

To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? No, Much Ado About Nothing!

The Case for a Trial of Medical Therapy

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

2016 CTO Revascularization Update

PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities

Diagnosis and Treatment of Erosion in ACS: The EROSION Study

Case Conclusion: How Did We Revascularize This Patient?

Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016!

Designing a Complication-Free DCB: Is It Possible or Necessary?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content